Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Molecular Weight: 810
indicating that LW8 degraded HIF-1alpha via regulation of VHL expression
2017 Mar 11
1 channel activator
Almorexant Hydrochloride Catalog No.:M8931-10 Molecular Weight: 810Almorexant HCl, also known as ACT 078573, is an orexin antagonist, functioning as a competitive receptor antagonist of the OX1 and OX2 orexin receptors, which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia. Development of the drug was abandoned in January 2011. Almorexant is a competitive, dual OX1 and OX2 receptor antagonist and selectively inhibits the functional consequences of OX1 and OX2
US$ 550000.00
US$ 440000.00
US$ 165000.00
US$ 740000.00
US$ 220000.00
US$ 82500.00
US$ 330000.00
US$ 113.09
US$ 412500.00
US$ 660000.00